Cyramza 100mg/10ml
Cyramza 100mg/10ml is a medicine authorised by Swissmedic under authorisation number 65206. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 October 2015 and the authorisation is valid without a time limit. ATC code L01FG02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 65206 |
|---|---|
| Name | Cyramza 100mg/10ml |
| Full name | Cyramza 100mg/10ml, concentré pour solution de perfusion |
| Authorisation holder | Eli Lilly (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FG02 |
| First authorisation | 29 October 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cyramza 100mg/10ml, concentré pour solution de perfusion | A | 29 October 2015 |
| 2 | Cyramza 500mg/50ml, concentré pour solution de perfusion | A | 29 October 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FG02 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FG02 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Cyramza 100mg/10ml authorised in Switzerland?
Yes. Cyramza 100mg/10ml is authorised by Swissmedic under authorisation number 65206, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Cyramza 100mg/10ml have?
Cyramza 100mg/10ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Cyramza 100mg/10ml?
The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.